CHICAGO — In patients with stage IVB anaplastic thyroid cancer, the inclusion of adjuvant pembrolizumab to conventional multimodal therapy shows significant benefits in reducing the recurrence ...

Keytruda (pembrolizumab) is a prescription drug that’s used to treat certain forms of cancer. Keytruda comes as an intravenous (IV) infusion (an injection into your vein given over time).

In a real-world diverse population of patients with early triple-negative breast cancer (TNBC), 34% of patients who received pembrolizumab developed immune-related adverse events — findings that ...

When combined with an immunotherapy drug called pembrolizumab (Keytruda), it reduces ... During that phase, patients received 1mg of the mRNA vaccine every three weeks. They also received 200mg ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...

Dr. Shannon Westin (Host), Dr. Brian Slomovitz (Guest) Dr. Shannon Westin and her guest, Dr. Brian Slomovitz discuss the article “Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without ...

The Inc42 & AWS series — Scaling From 1 To 10 — continues with a deep dive into online medicine delivery and healthtech platform 1mg. India is a unique market in many ways, but one of the ...

Adagene (ADAG) announced data at the SITC 39th Annual Meeting, taking place in Houston, Nov. 6 – 10, 2024. The two poster presentations ...

The phase 1 clinical program will include a phase 1b study of WM-A1 combined with the anti-PD-1 antibody pembrolizumab (Keytruda; Merck) in NSCLC, which will be conducted in collaboration with MSD.

Halozyme is investigating the use of pegvorhyaluronidase alfa in combination with Keytruda (pembrolizumab) to treat patients with metastatic NSCLC or gastric cancer. • Eisai and Halozyme are ...

To keep up to date with the latest Number 1s each week, sign up to our newsletter. Unsubscribe at any time.